Avidity Partners Management Lp Top Holdings and 13F Report (2024)

About Avidity Partners Management Lp

Investment Activity

Avidity Partners Management Lp has $1.96 billion in total holdings as of September 30, 2024.
Avidity Partners Management Lp owns shares of 81 different stocks, but just 39 companies or ETFs make up 80% of its holdings.
Approximately 20.59% of the portfolio was purchased this quarter.
About 49.81% of the portfolio was sold this quarter.
This quarter, Avidity Partners Management Lp has purchased 85 new stocks and bought additional shares in 13 stocks.
Avidity Partners Management Lp sold shares of 37 stocks and completely divested from 24 stocks this quarter.

Largest Holdings

Boston Scientific: $80,615,600
DIANTHUS THERAPEUTICS INC: $79,873,785
Intuitive Surgical: $72,806,214
Natera: $70,634,980
CG ONCOLOGY INC: $62,480,880

Largest New Holdings this Quarter

UnitedHealth Group: $51,101,032 Holding
Humana: $41,081,178 Holding
Centessa Pharmaceuticals: $34,090,680 Holding
Kymera Therapeutics: $23,665,000 Holding
BioMarin Pharmaceutical: $22,492,800 Holding

Largest Purchases this Quarter

UnitedHealth Group: 87,400 shares (about $51.10M)
Humana: 129,700 shares (about $41.08M)
Centessa Pharmaceuticals: 2,132,000 shares (about $34.09M)
Kymera Therapeutics: 500,000 shares (about $23.67M)
BioMarin Pharmaceutical: 320,000 shares (about $22.49M)

Largest Sales this Quarter

Avantor: 1,851,000 shares (about $47.89M)
Intuitive Surgical: 96,800 shares (about $47.55M)
Arvinas: 1,490,845 shares (about $36.72M)
AbbVie: 177,800 shares (about $35.11M)
Structure Therapeutics: 644,100 shares (about $28.27M)

Sector Allocation Over Time

Selling

Neutral

Buying

Latest 13F Holdings and Changes Since Previous Quarterly Filing

Issuer Name	Holdings Value	Approximate Purchase/Sale	Change in Shares	Shares Held	% of Portfolio	Sector
BSX Boston Scientific	$80,615,600	$17,438,780 ▼	-17.8%	962,000	4.1%	Medical
DIANTHUS THERAPEUTICS INC	$79,873,785		0.0%	2,917,231	4.1%	COM
ISRG Intuitive Surgical	$72,806,214	$47,554,936 ▼	-39.5%	148,200	3.7%	Medical
NTRA Natera	$70,634,980	$26,672,195 ▼	-27.4%	556,400	3.6%	Medical
CG ONCOLOGY INC	$62,480,880	$13,574,311 ▲	27.8%	1,656,000	3.2%	COM
ACHC Acadia Healthcare	$62,458,850	$8,560,350 ▼	-12.1%	985,000	3.2%	Medical
NBIX Neurocrine Biosciences	$53,001,200	$3,571,820 ▼	-6.3%	460,000	2.7%	Medical
UNH UnitedHealth Group	$51,101,032	$51,101,032 ▲	New Holding	87,400	2.6%	Medical
JAZZ Jazz Pharmaceuticals	$48,017,710	$12,645,035 ▼	-20.8%	431,000	2.4%	Medical
SNDX Syndax Pharmaceuticals	$47,258,750	$16,940,000 ▼	-26.4%	2,455,000	2.4%	Medical
PERSPECTIVE THERAPEUTICS INC	$45,977,427	$5,424,559 ▲	13.4%	3,444,002	2.3%	COM NEW
GKOS Glaukos	$44,933,572	$15,750,852 ▲	54.0%	344,900	2.3%	Medical
IDYA IDEAYA Biosciences	$43,496,640	$8,110,080 ▲	22.9%	1,373,000	2.2%	Medical
INSM Insmed	$43,216,000	$11,826,000 ▲	37.7%	592,000	2.2%	Medical
TMO Thermo Fisher Scientific	$42,433,902	$7,051,698 ▼	-14.3%	68,600	2.2%	Medical
THC Tenet Healthcare	$42,048,600	$19,777,800 ▼	-32.0%	253,000	2.1%	Medical
RARE Ultragenyx Pharmaceutical	$41,773,600	$11,554,400 ▼	-21.7%	752,000	2.1%	Medical
HUM Humana	$41,081,178	$41,081,178 ▲	New Holding	129,700	2.1%	Medical
EXAS Exact Sciences	$40,054,560	$16,995,940 ▲	73.7%	588,000	2.0%	Medical
ILMN Illumina	$38,079,720	$24,256,260 ▼	-38.9%	292,000	1.9%	Medical
ARVN Arvinas	$36,871,110	$36,719,512 ▼	-49.9%	1,497,000	1.9%	Medical
RVMD Revolution Medicines	$35,826,500	$1,587,250 ▲	4.6%	790,000	1.8%	Medical
CNTA Centessa Pharmaceuticals	$34,090,680	$34,090,680 ▲	New Holding	2,132,000	1.7%	Medical
PHAT Phathom Pharmaceuticals	$32,625,233	$3,335,633 ▲	11.4%	1,804,493	1.7%	Medical
XENE Xenon Pharmaceuticals	$32,204,660	$2,519,680 ▲	8.5%	818,000	1.6%	Medical
AVTR Avantor	$31,949,450	$47,885,370 ▼	-60.0%	1,235,000	1.6%	Medical
BPMC Blueprint Medicines	$29,137,500	$6,290,000 ▼	-17.8%	315,000	1.5%	Medical
MIRM Mirum Pharmaceuticals	$28,513,056		0.0%	731,104	1.5%	Medical
SGRY Surgery Partners	$26,662,480	$15,458,338 ▼	-36.7%	827,000	1.4%	Medical
AXSM Axsome Therapeutics	$26,610,507	$7,180,613 ▼	-21.3%	296,100	1.4%	Medical
DHR Danaher	$26,411,900	$15,291,100 ▼	-36.7%	95,000	1.3%	Multi-Sector Conglomerates
JANX Janux Therapeutics	$25,531,660	$12,639,489 ▼	-33.1%	562,000	1.3%	Medical
NEUMORA THERAPEUTICS INC.	$23,778,000		0.0%	1,800,000	1.2%	COM
KYMR Kymera Therapeutics	$23,665,000	$23,665,000 ▲	New Holding	500,000	1.2%	Medical
BHVN Biohaven	$23,236,050	$749,550 ▲	3.3%	465,000	1.2%	Medical
BMRN BioMarin Pharmaceutical	$22,492,800	$22,492,800 ▲	New Holding	320,000	1.1%	Medical
ARGX argenx	$20,707,456	$12,088,384 ▼	-36.9%	38,200	1.1%	Medical
INCY Incyte	$20,366,071	$14,600,829 ▼	-41.8%	308,110	1.0%	Medical
ABBV AbbVie	$19,748,000	$35,111,944 ▼	-64.0%	100,000	1.0%	Medical
ORUKA THERAPEUTICS INC	$19,385,596	$19,385,596 ▲	New Holding	790,926	1.0%	COM
GPCR Structure Therapeutics	$18,912,201	$28,269,549 ▼	-59.9%	430,900	1.0%	Medical
NEUROGENE INC	$17,834,720	$12,692,732 ▼	-41.6%	425,041	0.9%	COM
TERN Terns Pharmaceuticals	$17,796,492	$17,796,492 ▲	New Holding	2,133,872	0.9%	Medical
ASND Ascendis Pharma A/S	$17,767,890	$17,767,890 ▲	New Holding	119,000	0.9%	Medical
BNTX BioNTech	$17,221,650	$17,221,650 ▲	New Holding	145,000	0.9%	Medical
ITCI Intra-Cellular Therapies	$17,048,610	$12,219,390 ▼	-41.8%	233,000	0.9%	Medical
KROS Keros Therapeutics	$17,026,124	$2,903,500 ▼	-14.6%	293,200	0.9%	Medical
DXCM DexCom	$16,089,600	$1,273,760 ▼	-7.3%	240,000	0.8%	Medical
ORIC ORIC Pharmaceuticals	$14,832,970	$14,832,970 ▲	New Holding	1,447,119	0.8%	Medical
NAMS NewAmsterdam Pharma	$14,769,020	$5,484,640 ▲	59.1%	889,700	0.8%	Medical
CNTX Context Therapeutics	$14,537,624	$4,312 ▼	0.0%	7,417,155	0.7%	Medical
ZTS Zoetis	$13,871,980	$13,871,980 ▲	New Holding	71,000	0.7%	Medical
RCKT Rocket Pharmaceuticals	$13,834,030	$6,482,970 ▼	-31.9%	749,000	0.7%	Medical
IMUX Immunic	$13,638,900	$1,051,004 ▼	-7.2%	8,266,000	0.7%	Medical
BMY Bristol-Myers Squibb	$13,607,620	$13,607,620 ▲	New Holding	263,000	0.7%	Medical
IMNM Immunome	$12,776,286		0.0%	873,891	0.7%	Medical
RGNX REGENXBIO	$11,880,596	$1,757,075 ▼	-12.9%	1,132,564	0.6%	Medical
COGT Cogent Biosciences	$10,810,800	$3,175 ▲	0.0%	1,001,000	0.6%	Medical
APOGEE THERAPEUTICS INC	$9,045,960	$19,560,420 ▼	-68.4%	154,000	0.5%	COM
PRVA Privia Health Group	$8,500,428	$5,415,654 ▼	-38.9%	466,800	0.4%	Medical
CYBIN INC	$8,161,020	$8,161,020 ▲	New Holding	918,000	0.4%	COM NEW
ESTA Establishment Labs	$7,312,630	$15,663,740 ▼	-68.2%	169,000	0.4%	Medical
CGEM Cullinan Therapeutics	$7,114,500	$18,996,987 ▼	-72.8%	425,000	0.4%	Medical
IMCR Immunocore	$6,226,000		0.0%	200,000	0.3%	Medical
DYNE THERAPEUTICS INC	$5,926,800	$5,926,800 ▲	New Holding	165,000	0.3%	COM
SNY Sanofi	$5,763,000	$12,390,450 ▼	-68.3%	100,000	0.3%	Medical
EDIT Editas Medicine	$4,995,650	$2,213,090 ▲	79.5%	1,465,000	0.3%	Medical
TMDX TransMedics Group	$4,333,200	$4,333,200 ▲	New Holding	27,600	0.2%	Medical
KZR Kezar Life Sciences	$3,886,103		0.0%	5,026,000	0.2%	Medical
QURE uniQure	$3,320,937	$3,320,937 ▲	New Holding	673,618	0.2%	Medical
IMVT Immunovant	$2,822,490	$23,064,590 ▼	-89.1%	99,000	0.1%	Medical
ALTO NEUROSCIENCE INC	$2,745,600	$2,745,600 ▲	New Holding	240,000	0.1%	COM SHS
PRME Prime Medicine	$2,685,780		0.0%	694,000	0.1%	Medical
SYRS Syros Pharmaceuticals	$2,285,450	$1,312,657 ▼	-36.5%	1,063,000	0.1%	Medical
SCYX SCYNEXIS	$2,158,605		0.0%	1,448,728	0.1%	Medical
INSTIL BIO INC	$1,959,012	$1,959,012 ▲	New Holding	29,100	0.1%	COM NEW
PRLD Prelude Therapeutics	$1,842,300	$1,842,300 ▲	New Holding	890,000	0.1%	Medical
KPTI Karyopharm Therapeutics	$1,675,355		0.0%	2,018,500	0.1%	Medical
HYPR Hyperfine	$1,283,232		0.0%	1,188,178	0.1%	Medical
BLUE bluebird bio	$847,379	$847,379 ▲	New Holding	1,631,143	0.0%	Medical
CAREMAX INC	$36,040		0.0%	21,200	0.0%	CL A NEW
CI The Cigna Group	$0	$60,990,165 ▼	-100.0%	0	0.0%	Medical
ALNY Alnylam Pharmaceuticals	$0	$53,946,000 ▼	-100.0%	0	0.0%	Medical
REGN Regeneron Pharmaceuticals	$0	$50,449,440 ▼	-100.0%	0	0.0%	Medical
MRK Merck & Co., Inc.	$0	$40,235,000 ▼	-100.0%	0	0.0%	Medical
UTHR United Therapeutics	$0	$35,040,500 ▼	-100.0%	0	0.0%	Medical
LNTH Lantheus	$0	$23,284,100 ▼	-100.0%	0	0.0%	Medical
PCVX Vaxcyte	$0	$21,444,840 ▼	-100.0%	0	0.0%	Medical
JASPER THERAPEUTICS INC	$0	$17,751,400 ▼	-100.0%	0	0.0%	COM NEW
LEGN Legend Biotech	$0	$17,627,420 ▼	-100.0%	0	0.0%	Medical
GILD Gilead Sciences	$0	$17,495,550 ▼	-100.0%	0	0.0%	Medical
AZN AstraZeneca	$0	$15,987,950 ▼	-100.0%	0	0.0%	Medical
CRBP Corbus Pharmaceuticals	$0	$9,755,900 ▼	-100.0%	0	0.0%	Medical
CYBIN INC	$0	$9,453,564 ▼	-100.0%	0	0.0%	COM
TYRA Tyra Biosciences	$0	$5,964,270 ▼	-100.0%	0	0.0%	Medical
PATH UiPath	$0	$4,590,160 ▼	-100.0%	0	0.0%	Business Services
SPYRE THERAPEUTICS INC	$0	$4,584,450 ▼	-100.0%	0	0.0%	COM NEW
IMTX Immatics	$0	$4,567,822 ▼	-100.0%	0	0.0%	Medical
IONS Ionis Pharmaceuticals	$0	$4,432,380 ▼	-100.0%	0	0.0%	Medical
ABIO ARCA biopharma	$0	$3,830,000 ▼	-100.0%	0	0.0%	Medical

Showing largest 100 holdings. View all holdings.

More Institutional Buying and Selling Information

SEC Filings and Trading Data

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Avidity Partners Management Lp Top Holdings and 13F Report (2024)

About Avidity Partners Management Lp

Investment Activity

Largest Holdings

Largest New Holdings this Quarter

Largest Purchases this Quarter

Largest Sales this Quarter

Sector Allocation Over Time

Latest 13F Holdings and Changes Since Previous Quarterly Filing

More Institutional Buying and Selling Information

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Avidity Partners Management Lp Top Holdings and 13F Report (2024)

About Avidity Partners Management Lp

Investment Activity

Largest Holdings

Largest New Holdings this Quarter

Largest Purchases this Quarter

Largest Sales this Quarter

Sector Allocation Over Time

Map of 500 Largest Holdings ofAvidity Partners Management Lp

Latest 13F Holdings and Changes Since Previous Quarterly Filing

More Institutional Buying and Selling Information

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools